Insulet Corporation (NASDAQ:PODD) Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ET

Company Participants

Deborah Gordon - Vice President of Investor Relations
Jim Hollingshead - President and Chief Executive Officer
Ana Maria Chadwick - Executive Vice President, Chief Financial Officer and Treasurer

Conference Call Participants

Robert Marcus - JPMorgan
Jeffrey Johnson - Baird
Travis Steed - Bank of America
Michael Polark - Wolfe Research
Danielle Antalffy - UBS
Patrick Wood - Morgan Stanley
Lawrence Biegelsen - Wells Fargo
Issie Kirby - Redburn Atlantic
Mike Kratky - Leerink Partners
Jayson Bedford - Raymond James
Matt Taylor - Jefferies
Matthew O'Brien - Piper Sandler
Chris Pasquale - Nephron Research
Joanne Wuensch - Citi
Matt Miksic - Barclays
Bill Plovanic - Canaccord

Operator

Good afternoon, ladies and gentlemen, and welcome to the Insulet Corporation Third Quarter 2024 Earnings Call. At this time, all participants are in a listen-only mode. Later we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions] As a reminder, this conference call is being recorded.

I would now like to turn the conference over to your host, Deborah Gordon, Vice President, Investor Relations.

Deborah Gordon

Thank you. Good afternoon, and thank you for joining us for Insulet's third quarter 2024 earnings call. With me today are Jim Hollingshead, President and Chief Executive Officer; Ana Maria Chadwick, Chief Financial Officer and Treasurer.

Both the replay of this call and the press release discussing our third quarter results and 2024 guidance will be available on the Investor Relations section of our website. Also on our website is our supplemental earnings presentation. We encourage you to reference that document for a summary of key metrics and business updates.

Before we begin, we remind you that certain statements made by Insulet during the course of this call may be forward-looking and could materially differ from current expectations. Please refer to the cautionary statements in our SEC filings for a detailed explanation of the inherent limitations of such statements.

We'll also discuss non-GAAP financial measures with respect to our performance, namely adjusted EBITDA and constant currency revenue, which is revenue growth, excluding the effect of foreign exchange. These measures align with what management uses as supplemental measures in assessing our operating performance from period to period, and we believe they are helpful for others as well. Additionally, unless otherwise stated, all financial commentary regarding dollar and percentage changes will be on a year-over-year reported basis, with the exception of revenue growth rates, which will be on a year-over-year constant currency basis.